Intravitreal Methotrexate and R2(Rituximab & Lenalidomide) Regimen in Newly-diagnosed Primary Vitreoretinal Lymphoma

NCT03746223 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Primary Intraocular Lymphoma

Interventions

DRUG: Methotrexate
DRUG: Rituximab
DRUG: Lenalidomide

Sponsor

Peking Union Medical College Hospital